Tricyclic Antidepressants

Tricyclic antidepressants (TCAs) stand as a trademark throughout the entire existence of psychopharmacology, addressing a critical headway in the treatment of despondency and related mental issues. This class of meds, described by their tricyclic synthetic construction, plays had a significant impact in forming the scene of present day mental pharmacotherapy. Understanding the presentation and advancement of TCAs is fundamental to see the value in their effect on clinical practice and patient consideration.